1
|
Hervé RC, Bryant C, Sutton L, Cox C, Gião MS, Keevil CW, Wilks SA. Impact of different hand-drying methods on surrounding environment: aerosolization of virus and bacteria, and transfer to surfaces. J Hosp Infect 2024; 147:197-205. [PMID: 38521417 DOI: 10.1016/j.jhin.2024.03.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2023] [Revised: 02/27/2024] [Accepted: 03/09/2024] [Indexed: 03/25/2024]
Abstract
BACKGROUND In recent years, hand drying has been highlighted as a key step in appropriate hand hygiene, as moisture on hands can increase the transfer of micro-organisms from hands to surfaces and vice versa. AIM To understand bacterial and viral aerosolization following hand drying, and study the transfer of micro-organisms from hands to surfaces after drying using different methods. METHODS Groups of five volunteers had their hands pre-washed with soap, rinsed and dried, then inoculated with a concentrated mixture of Pseudomonas fluorescens and MS2 bacteriophage. Volunteers entered an empty washroom, one at a time, and rinsed their hands with water or washed their hands with soap prior to drying with a jet dryer or paper towels. Each volunteer applied one hand successively to various surfaces, while their other hand was sampled using the glove juice method. Both residual bacteria and viruses were quantified from the washroom air, surface swabs and hand samples. FINDINGS P. fluorescens and MS2 bacteriophages were rarely aerosolized while drying hands for any of the drying methods studied. Results also showed limited, and similar, transfer of both micro-organisms studied on to surfaces for all drying methods. CONCLUSION The use of jet dryers or paper towels produces low levels of aerosolization when drying hands in a washroom. Similarly, all drying methods result in low transfer to surfaces. While the coronavirus disease 2019 pandemic raised concerns regarding public washrooms, this study shows that all methods tested are hygienic solutions for dry washed hands.
Collapse
Affiliation(s)
- R C Hervé
- School of Biological Sciences, University of Southampton, Southampton, UK.
| | - C Bryant
- School of Biological Sciences, University of Southampton, Southampton, UK
| | - L Sutton
- School of Biological Sciences, University of Southampton, Southampton, UK
| | - C Cox
- School of Biological Sciences, University of Southampton, Southampton, UK
| | - M S Gião
- Dyson Technology Ltd, Malmesbury, UK
| | - C W Keevil
- School of Biological Sciences, University of Southampton, Southampton, UK
| | - S A Wilks
- School of Biological Sciences, University of Southampton, Southampton, UK
| |
Collapse
|
2
|
Shea L, Akhave N, Sutton L, Compton L, York C, Ramakrishnan S, Miller C, Wartman L, Chen D. 104 Loss of Kdm6a and Trp53 drives the development of squamous cell skin cancer in mice. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
3
|
Ray X, Sumner W, Sutton L, Sanghvi P, Deichaite I, Moiseenko V. PO-0948 Impact of HPV status on normal tissue toxicities experienced by head & neck cancer patients. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07399-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
4
|
Affiliation(s)
- Z S Patel
- Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA
| | - L K Hoffman
- Albert Einstein College of Medicine, Bronx, NY, USA.,Montefiore Medical Center, Bronx, NY, USA
| | - L Sutton
- Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA
| | - S R Cohen
- Albert Einstein College of Medicine, Bronx, NY, USA.,Montefiore Medical Center, Bronx, NY, USA
| | - M A Lowes
- The Rockefeller University, New York, NY, USA
| | - E K Seng
- Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA.,Saul R. Korey Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
| |
Collapse
|
5
|
Pine CM, Adair PM, Burnside G, Brennan L, Sutton L, Edwards RT, Ezeofor V, Albadri S, Curnow MM, Deery C, Hosey MT, Willis-Lake J, Lynn J, Parry J, Wong FSL. Dental RECUR Randomized Trial to Prevent Caries Recurrence in Children. J Dent Res 2020; 99:168-174. [PMID: 31944893 DOI: 10.1177/0022034519886808] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
The purpose of this study was to determine the efficacy of a dental nurse-delivered intervention-the Dental RECUR Brief Negotiated Interview for Oral Health (DR-BNI)-in reducing the recurrence of dental caries in children who have a primary tooth extracted. It was based on a 2-arm multicenter randomized controlled trial with blinded outcome assessment. Participants were 5- to 7-y-old children (n = 241) scheduled to have primary teeth extracted in 12 UK centers. Test intervention parents (n = 119) received DR-BNI led by trained dental nurses. DR-BNI is a 30-min structured conversation informed by motivational interviewing with a forward focus to prevent future caries. Preventive goals are agreed, and a review appointment is made with child's general dental practitioner, who is advised to treat the child as being at high caries risk. The control intervention (n = 122) was a parent-nurse conversation about child's future tooth eruption, with advice given to visit a general dental practitioner as usual. At baseline, the DR-BNI group's mean dmft was 6.8, and the control group's was 6.3. A median of 5 teeth were extracted, mainly under general anesthesia. Final dental assessments were conducted by a single examiner visiting 189 schools 2 y after intervention; 193 (80%) of 241 children were examined. In the control group, 62% developed new caries in teeth that were caries-free or unerupted at baseline, as compared with 44% in the test group, a significant reduction (P = 0.021). The odds of new caries experience occurring were reduced by 51% in the DR-BNI group as compared with control. There was a 29% decrease in the relative risk of new caries experience in the DR-BNI group as compared with control. This single low-cost, low-intensity intervention was successful in significantly reducing the risk of recurrence of dental caries in children. This trial has implications for changing pediatric dental practice internationally. Training in and implementation of a motivational interviewing-informed brief intervention provides opportunities for dental nurses to facilitate behavior change improving the oral health of children at high caries risk (ISRCTN 24958829).
Collapse
Affiliation(s)
- C M Pine
- Research and Innovation, Salford Royal NHS Foundation Trust, Northern Care Alliance NHS Group, Summerfield House, Salford, UK.,Barts and the London Schools of Medicine and Dentistry, Institute of Dentistry, Queen Mary University of London, London, UK
| | - P M Adair
- Centre for Improving Health-Related Quality of Life, School of Psychology, Queen's University, Belfast, UK
| | - G Burnside
- Department of Biostatistics, University of Liverpool, Liverpool, UK
| | - L Brennan
- Health Education North West, Regatta Place, Liverpool, UK
| | - L Sutton
- Department of Biostatistics, University of Liverpool, Liverpool, UK
| | - R T Edwards
- Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK
| | - V Ezeofor
- Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK
| | - S Albadri
- Paediatric Dentistry, School of Dentistry, University of Liverpool, Liverpool, UK
| | - M M Curnow
- Public Dental Service, Broxden Dental Centre, NHS Tayside, Perth, UK
| | - C Deery
- School of Clinical Dentistry, University of Sheffield, Sheffield, UK
| | - M T Hosey
- Paediatric Dentistry, Centre of Oral, Clinical and Translational Science, Faculty of Dentistry, Oral and Craniofacial Sciences, Kings College London, London, UK
| | - J Willis-Lake
- Kent Community Health NHS Foundation Trust, Maidstone, UK
| | - J Lynn
- Community Dental Service, Arches Health and Care Centre, Belfast Health and Social Care Trust, Belfast, UK
| | - J Parry
- Special Care Dental Service, Sussex Community NHS Foundation Trust, Brighton, UK.,Paediatric Dentistry, University College Cork, Cork, Ireland
| | - F S L Wong
- Barts and the London Schools of Medicine and Dentistry, Institute of Dentistry, Queen Mary University of London, London, UK
| |
Collapse
|
6
|
Alex P, Williams S, Sutton L, Yesudas T, Sutton C, Thomas S, Centola M. Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open-label randomized comparative pilot clinical study. Clin Exp Dermatol 2019; 45:318-322. [PMID: 31419323 PMCID: PMC7154690 DOI: 10.1111/ced.14074] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2018] [Revised: 07/25/2019] [Accepted: 08/13/2019] [Indexed: 11/26/2022]
Abstract
Psoriasis is commonly treated with topical corticosteroids, oral cytotoxic drugs and biologic agents, which can be associated with significant adverse effects (AEs), high cost and response attenuation. Additionally, patients often use alternative therapies ad hoc, which can be challenging to integrate into a treatment regimen, owing to a lack of adequately powered controlled trials assessing efficacy and safety. We developed a novel topical botanical complex, herbal anti‐inflammatory treatment (HAT1), through extensive preclinical in vitro and in vivo modelling to define key mechanisms of action and clinical potential. To assess the efficacy and safety of HAT1 in psoriasis, we performed a 10‐week, open‐label, pilot clinical trial comparing topical treatment of HAT1 with calcipotriol 0.005% in adult patients with mild to moderate psoriasis. Primary and secondary endpoints included the percentage of patients obtaining improvement of ≥ 75% in Psoriasis Area and Severity Index (PASI 75), Physician’s Global Assessment (PGA) response, and evaluation of tolerability and safety of HAT1. In the HAT1 arm, 85.7% of study patients reached PASI 75 compared with 21.4% in the calcipotriol comparator group. Additionally, 78.6% of patients in the HAT1 arm achieved a ‘clear’ or ‘minimal’ PGA response. HAT1 was well tolerated, with no AEs observed throughout the trial. These results suggest that HAT1 reduces psoriasis disease activity in a clinically relevant manner. Ongoing studies, including well‐powered, double‐blind, randomized controlled trials will be required to assess the potential of HAT1 in psoriasis.
Collapse
Affiliation(s)
- P Alex
- Haus Clinical Research Program, Haus Bioceuticals, Oklahoma City, OK, USA
| | - S Williams
- Haus Clinical Research Program, Haus Bioceuticals, Oklahoma City, OK, USA
| | - L Sutton
- Haus Clinical Research Program, Haus Bioceuticals, Oklahoma City, OK, USA
| | - T Yesudas
- Haus Clinical Research Program, Haus Bioceuticals, Oklahoma City, OK, USA
| | - C Sutton
- Haus Clinical Research Program, Haus Bioceuticals, Oklahoma City, OK, USA
| | - S Thomas
- Haus Clinical Research Program, Haus Bioceuticals, Oklahoma City, OK, USA
| | - M Centola
- Haus Clinical Research Program, Haus Bioceuticals, Oklahoma City, OK, USA
| |
Collapse
|
7
|
Abstract
We studied the temperature dependence of the magnetic properties of VO2/Ni bilayers. The Ni films were deposited on either monoclinic or rutile phase VO2. The temperature induced VO2 transformation from a monoclinic to a rutile structure induces strain in the Ni film. Due to an inverse magnetoelastic effect the coercivity of the Ni films is strongly modified. Both Ni films show strong enhancement of the coercivity near the transition temperature. The coercivity enhancement of Ni is associated with the phase coexistence observed in the VO2 first order phase transition. Above the transition temperature, Ni deposited on monoclinic VO2 shows a coercivity enhancement whereas Ni deposited on rutile VO2 shows suppression of the coercivity. The samples were cycled several times to check if the changes in coercivity were reversible. While samples with Ni deposited on rutile VO2 show reversibility, samples with Ni deposited on monoclinic VO2 shown an irreversibility after the first structural phase transition. This irreversibility can be associated with cracking of the VO2 layer as it relieves stress due to the transition and has implications for the resistance versus temperature behavior of the VO2.
Collapse
Affiliation(s)
- J Lauzier
- Department of Physics, Colorado State University, Fort Collins, CO 80523, United States of America
| | | | | |
Collapse
|
8
|
Sutton L, Mozaffari M, Mintarti A, Indrasari SR, Narula A, Lechner M. Barriers to improving tracheostomy care in low- and middle-income countries: Our experience of a 23 patient closed loop audit cycle. Clin Otolaryngol 2018; 43:1392-1395. [PMID: 29802686 DOI: 10.1111/coa.13151] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/23/2018] [Indexed: 11/28/2022]
Affiliation(s)
- L Sutton
- Head and Neck Centre, University College London Hospitals NHS Trust, London, UK.,UCL Cancer Institute, University College London, London, UK
| | - M Mozaffari
- UCL Cancer Institute, University College London, London, UK
| | - A Mintarti
- Faculty of Medicine, Department of ENT H&N Surgery, Universitas GadjahMada/Sardjito Hospital, Yogyakarta, Indonesia
| | - S R Indrasari
- Faculty of Medicine, Department of ENT H&N Surgery, Universitas GadjahMada/Sardjito Hospital, Yogyakarta, Indonesia
| | - A Narula
- ENT UK, Royal College of Surgeons, London, UK
| | - M Lechner
- Head and Neck Centre, University College London Hospitals NHS Trust, London, UK.,UCL Cancer Institute, University College London, London, UK.,Royal National Throat, Nose and Ear Hospital, University College London Hospitals NHS Trust, London, UK
| |
Collapse
|
9
|
Sutton L, Schartinger V, Url C, Schmutzhard J, Lechner D, Kavasogullari C, Sandhu JS, Shaida A, Laszig R, Loehler J, Plontke S, Riechelmann H, Lechner M. Intratympanic steroid use for idiopathic sudden sensorineural hearing loss: current otolaryngology practice in Germany and Austria. Eur Arch Otorhinolaryngol 2018; 275:1103-1110. [PMID: 29605865 DOI: 10.1007/s00405-018-4958-8] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2017] [Accepted: 03/27/2018] [Indexed: 01/23/2023]
Abstract
AIMS The frequency of the use of intratympanic steroids (ITS) as a treatment for idiopathic sudden sensorineural hearing loss (ISSNHL) in Europe is still unknown and remains a contentious issue amongst otolaryngologists. We undertook a survey of otolaryngologists in Germany and Austria to establish if there is any professional consensus with which to form a protocol for its use. METHODS A survey of 21 questions was distributed electronically to otolaryngologists in Germany and Austria and data on demographics, indications for intratympanic treatment, procedure, follow-up, and outcomes were analysed. RESULTS We received 908 responses. 49.1% of otolaryngologists used ITS for ISSNHL. Of those otolaryngologists who use ITS, 73.7% do not use it as primary treatment. 20.6% use ITS in conjunction with oral steroids for primary treatment and only 5.8% use ITS as monotherapy for primary treatment. 90.5% use ITS as salvage therapy. 81.1% do not consider the use of ITS after 2 weeks from the onset of symptoms. 8.3% used a tympanostomy tube and while the most commonly used steroid was dexamethasone at a concentration of 4 mg/ml (61%), a wide variety or other steroids and concentrations were used. CONCLUSIONS This survey illustrates wide variation of current practice of intratympanic corticosteroid injection for ISSHL in Germany and Austria. In the absence of high-level evidence, knowing what current practice is allows clinicians to assess what they do against what their colleagues are doing, and if they do something very different, make them question their practice. Moreover, the obtained data will help to direct future clinical trials with the aim to compare the outcomes of more commonly used protocols.
Collapse
Affiliation(s)
- L Sutton
- Head and Neck Centre, University College London Hospitals NHS Trust, Euston Road, London, NW1 2PG, UK
- UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6DD, UK
| | - V Schartinger
- Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Innsbruck, Anichstr., Innsbruck, Austria
| | - C Url
- Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Innsbruck, Anichstr., Innsbruck, Austria
| | - J Schmutzhard
- Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Innsbruck, Anichstr., Innsbruck, Austria
| | - D Lechner
- Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Innsbruck, Anichstr., Innsbruck, Austria
| | | | - J S Sandhu
- Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S5 7AT, UK
| | - A Shaida
- Royal National Throat, Nose and Ear Hospital, University College London Hospitals NHS Trust, 330 Grays Inn Road, London, WC1X 8DA, UK
| | - R Laszig
- Department of Otorhinolaryngology, University Hospital of Freiburg, Breisacher Str., Freiburg, Germany
| | - J Loehler
- ENT Clinic, Maienbeeck, Bad Bramstedt, Germany
| | - S Plontke
- Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Halle, Ernst-Grube-Str., Halle, Germany
| | - H Riechelmann
- Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Innsbruck, Anichstr., Innsbruck, Austria
| | - M Lechner
- Head and Neck Centre, University College London Hospitals NHS Trust, Euston Road, London, NW1 2PG, UK.
- UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6DD, UK.
- Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Innsbruck, Anichstr., Innsbruck, Austria.
- Royal National Throat, Nose and Ear Hospital, University College London Hospitals NHS Trust, 330 Grays Inn Road, London, WC1X 8DA, UK.
| |
Collapse
|
10
|
Smith DR, King RFGJ, Duckworth LC, Sutton L, Preston T, O'Hara JP, Jones B. Energy expenditure of rugby players during a 14-day in-season period, measured using doubly labelled water. Eur J Appl Physiol 2018; 118:647-656. [PMID: 29353321 PMCID: PMC5805815 DOI: 10.1007/s00421-018-3804-4] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2017] [Accepted: 01/11/2018] [Indexed: 11/24/2022]
Abstract
Criterion data for total energy expenditure (TEE) in elite rugby are lacking, which prediction equations may not reflect accurately. This study quantified TEE of 27 elite male rugby league (RL) and rugby union (RU) players (U16, U20, U24 age groups) during a 14-day in-season period using doubly labelled water (DLW). Measured TEE was also compared to estimated, using prediction equations. Resting metabolic rate (RMR) was measured using indirect calorimetry, and physical activity level (PAL) estimated (TEE:RMR). Differences in measured TEE were unclear by code and age (RL 4369 ± 979; RU 4365 ± 1122; U16, 4010 ± 744; U20, 4414 ± 688; U24, 4761 ± 1523 Kcal day- 1). Differences in PAL (overall mean 2.0 ± 0.4) were unclear. Very likely differences were observed in RMR by code (RL 2366 ± 296; RU 2123 ± 269 Kcal day- 1). Differences in relative RMR between U20 and U24 were very likely (U16, 27 ± 4; U20, 23 ± 3; U24, 26 ± 5 Kcal kg- 1 day- 1). Differences were observed between measured and estimated TEE, using Schofield, Cunningham and Harris-Benedict equations for U16 (187 ± 614, unclear; - 489 ± 564, likely and - 90 ± 579, unclear Kcal day- 1), U20 (- 449 ± 698, likely; - 785 ± 650, very likely and - 452 ± 684, likely Kcal day- 1) and U24 players (- 428 ± 1292; - 605 ± 1493 and - 461 ± 1314 Kcal day- 1, all unclear). Rugby players have high TEE, which should be acknowledged. Large inter-player variability in TEE was observed demonstrating heterogeneity within groups, thus published equations may not appropriately estimate TEE.
Collapse
Affiliation(s)
- Deborah R Smith
- Institute for Sport, Physical Activity and Leisure, Leeds Beckett University, G19 Fairfax Hall, Headingley Campus, Leeds, LS6 3QN, UK.
- Leeds Rhinos RLFC, Leeds, UK.
- Yorkshire Carnegie RUFC, Leeds, UK.
| | - R F G J King
- Institute for Sport, Physical Activity and Leisure, Leeds Beckett University, G19 Fairfax Hall, Headingley Campus, Leeds, LS6 3QN, UK
| | - L C Duckworth
- Institute for Sport, Physical Activity and Leisure, Leeds Beckett University, G19 Fairfax Hall, Headingley Campus, Leeds, LS6 3QN, UK
| | - L Sutton
- Institute for Sport, Physical Activity and Leisure, Leeds Beckett University, G19 Fairfax Hall, Headingley Campus, Leeds, LS6 3QN, UK
| | - T Preston
- Stable Isotope Biochemistry Laboratory, Scottish Universities Environmental Research Centre, East Kilbride, UK
| | - J P O'Hara
- Institute for Sport, Physical Activity and Leisure, Leeds Beckett University, G19 Fairfax Hall, Headingley Campus, Leeds, LS6 3QN, UK
| | - B Jones
- Institute for Sport, Physical Activity and Leisure, Leeds Beckett University, G19 Fairfax Hall, Headingley Campus, Leeds, LS6 3QN, UK
- Yorkshire Carnegie RUFC, Leeds, UK
- The Rugby Football League, Leeds, UK
| |
Collapse
|
11
|
Sutton L, Edwards D, McColl M. Outpatient negative pressure dressing therapy for pretibial lacerations in a patient with high anaesthetic risk: a case study. J Wound Care 2017; 26:762-764. [PMID: 29244964 DOI: 10.12968/jowc.2017.26.12.762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Pretibial lacerations are a common cause of presentation to accident and emergency departments. The management of these wounds is contentious with a variation in practise between individual institutions. We present the case of a 49-year-old female with a background of pulmonary atresia and associated pulmonary hypertension, who underwent successful outpatient negative pressure wound therapy (NPWT) for three pretibial lacerations. We would propose that this therapy is an effective option for the management of these wounds in independently mobile patients who are at high-risk when under anaesthetic.
Collapse
Affiliation(s)
- L Sutton
- Otolarygology Specialist, Head and Neck Centre, University College London Hospitals NHS Trust, London, UK; UCL Cancer Institute, University College London, London, UK
| | - D Edwards
- Lead Nurse, Burns and Plastic Surgery, Plastic Surgery Department, The Royal London Hospital, Barts Health NHS Trust, London, UK
| | | |
Collapse
|
12
|
Morton J, Pickels M, Sutton L. The Correlation of the Bga Blood Group with the HL-A7
Leucocyte Group: Demonstration of Antigenic Sites
on Red Cells and Leucocytes. Vox Sang 2017. [DOI: 10.1159/000465864] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
13
|
|
14
|
Cosson A, Chapiro E, Bougacha N, Lambert J, Herbi L, Cung HA, Algrin C, Keren B, Damm F, Gabillaud C, Brunelle-Navas MN, Davi F, Merle-Béral H, Le Garff-Tavernier M, Roos-Weil D, Choquet S, Uzunov M, Morel V, Leblond V, Maloum K, Lepretre S, Feugier P, Lesty C, Lejeune J, Sutton L, Landesman Y, Susin SA, Nguyen-Khac F. Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1. Leukemia 2017; 31:1625-1629. [PMID: 28344316 DOI: 10.1038/leu.2017.100] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
MESH Headings
- Apoptosis
- Chromosomes, Human, Pair 2
- Drug Resistance, Neoplasm/drug effects
- Drug Resistance, Neoplasm/genetics
- Gene Expression Regulation, Leukemic
- Humans
- Hydrazines/pharmacology
- Hydrazines/therapeutic use
- Karyopherins/genetics
- Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy
- Leukemia, Lymphocytic, Chronic, B-Cell/genetics
- Receptors, Cytoplasmic and Nuclear/genetics
- Triazoles/pharmacology
- Triazoles/therapeutic use
- Exportin 1 Protein
Collapse
Affiliation(s)
- A Cosson
- INSERM UMR_S 1138, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, Paris, France
- Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
- Université Paris Descartes, Sorbonne Paris Cité, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
| | - E Chapiro
- INSERM UMR_S 1138, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, Paris, France
- Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - N Bougacha
- INSERM UMR_S 1138, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, Paris, France
- Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
- Université Paris Descartes, Sorbonne Paris Cité, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
| | - J Lambert
- Service de Biostatistique et Informatique Médicale, Hôpital Saint Louis, Paris, France
| | - L Herbi
- INSERM UMR_S 1138, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, Paris, France
- Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
- Université Paris Descartes, Sorbonne Paris Cité, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
| | - H-A Cung
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - C Algrin
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - B Keren
- Département de génétique, GH Pitié-Salpêtrière, Paris, France
| | - F Damm
- INSERM U1170, Institut Gustave Roussy, Villejuif, France
| | - C Gabillaud
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - M-N Brunelle-Navas
- INSERM UMR_S 1138, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, Paris, France
- Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
- Université Paris Descartes, Sorbonne Paris Cité, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
| | - F Davi
- INSERM UMR_S 1138, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, Paris, France
- Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - H Merle-Béral
- INSERM UMR_S 1138, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, Paris, France
- Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - M Le Garff-Tavernier
- INSERM UMR_S 1138, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, Paris, France
- Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - D Roos-Weil
- INSERM U1170, Institut Gustave Roussy, Villejuif, France
| | - S Choquet
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - M Uzunov
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - V Morel
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - V Leblond
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - K Maloum
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - S Lepretre
- Département d'Hématologie, Hôpital Becquerel, Rouen, France
| | - P Feugier
- Pôle d'Hématologie, Hôpital Brabois, Vandoeuvre-les-Nancy, France
| | - C Lesty
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| | - J Lejeune
- Service de Biostatistique et Informatique Médicale, Hôpital Saint Louis, Paris, France
| | - L Sutton
- Service d'Hématologie Clinique, Hôpital d'Argenteuil, Argenteuil, France
| | | | - S A Susin
- INSERM UMR_S 1138, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, Paris, France
- Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
- Université Paris Descartes, Sorbonne Paris Cité, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
| | - F Nguyen-Khac
- INSERM UMR_S 1138, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, Paris, France
- Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
- Service d'Hématologie Biologique, GH Pitié-Salpêtrière, Paris, France
| |
Collapse
|
15
|
Hunault-Berger M, Maillard N, Himberlin C, Recher C, Schmidt-Tanguy A, Choufi B, Bonmati C, Carré M, Couturier MA, Daguindau E, Marolleau JP, Orsini-Piocelle F, Delaunay J, Tavernier E, Lissandre S, Ojeda-Uribe M, Sanhes L, Sutton L, Banos A, Fornecker LM, Bernard M, Bouscary D, Saad A, Puyade M, Rouillé V, Luquet I, Béné MC, Hamel JF, Dreyfus F, Ifrah N, Pigneux A. Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial. Blood Cancer J 2017; 7:e568. [PMID: 28574488 PMCID: PMC5520397 DOI: 10.1038/bcj.2017.50] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Affiliation(s)
- M Hunault-Berger
- Maladies du Sang, CHU Angers, CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France
| | - N Maillard
- Service d'Hématologie, CHU Poitiers, Poitiers, France
| | - C Himberlin
- Service d'Hématologie, CHU Reims, Reims, France
| | - C Recher
- Hématologie Clinique, CHU, Institut Universitaire du Cancer Toulouse-Oncopole, CRCT UMR1037, Université de Toulouse III, Toulouse, France
| | - A Schmidt-Tanguy
- Maladies du Sang, CHU Angers, CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France
| | - B Choufi
- Service d'Hématologie, CH Boulogne, Boulogne, France
| | - C Bonmati
- Service d'Hématologie, CHU Nancy, Nancy, France
| | - M Carré
- Service d'Hématologie, UMR 5525, CHU Grenoble Alpes, La Tronche, France
| | - M-A Couturier
- Institut d'Hématologie et de Cancérologie, Hôpital Augustin Morvan, Brest, France
| | - E Daguindau
- Service d'Hématologie, CHU Besançon, Besançon, France
| | | | | | - J Delaunay
- Service d'Hématologie, CHU Nantes, Nantes, France
| | - E Tavernier
- Service d'Hématologie, Institut de Cancérologie de la Loire, Saint Etienne, France
| | - S Lissandre
- Service d'Hématologie et thérapie cellulaire, CHU, Tours, France
| | - M Ojeda-Uribe
- Service d'Hématologie, CH Mulhouse, Mulhouse, France
| | - L Sanhes
- Service d'Hématologie, CH Perpignan, Perpignan, France
| | - L Sutton
- Service d'Hématologie, CH Argenteuil, Argenteuil, France
| | - A Banos
- Service d'Hématologie, CH Côte Basque, Bayonne, France
| | - L M Fornecker
- Département d'Hématologie et d'Oncologie, CHU Hautepierre, Strasbourg, France
| | - M Bernard
- Hématologie Clinique, Hôpital Pontchaillou, Rennes, France
| | - D Bouscary
- Hématologie Clinique, Hôpital Cochin, APHP, Paris, France
| | - A Saad
- Hématologie, CH Béziers, Béziers, France
| | - M Puyade
- Service d'Hématologie, CHU Poitiers, Poitiers, France
| | - V Rouillé
- Service Hématologie, Hôpital Lapeyronie, Montpellier, France
| | - I Luquet
- Hématologie Biologique, CHU, IUC Toulouse-Oncopole, Toulouse, France
| | - M C Béné
- Hématologie Biologique, CHU de Nantes, Nantes, France
| | - J-F Hamel
- Maladies du Sang, CHU Angers, CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France
| | - F Dreyfus
- Hématologie Clinique, Hôpital Cochin, APHP, Paris, France
| | - N Ifrah
- Maladies du Sang, CHU Angers, CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France
| | - A Pigneux
- Hématologie Clinique, CHU Bordeaux, Inserm 1035, Bordeaux, France
| |
Collapse
|
16
|
Dietrich S, Oleś M, Sellner L, Anders S, Lu J, Velten B, Mock A, Oakes C, Sutton L, Young E, Rosenquist R, Rossi D, Zirlik K, Herling M, Nguyen-Khac F, Plass C, von Kalle C, Dürig J, Ringshausen I, Huber W, Zenz T. DRUG PERTURBATION BASED STRATIFICATION OF LYMPHOPROLIFERATIVE DISORDERS. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_41] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- S. Dietrich
- Department of Hematology; University Hospital of Heidelberg; Heidelberg Germany
| | - M. Oleś
- Genome Biology; EMBL; Heidelberg Germany
| | - L. Sellner
- Department of Hematology; University Hospital of Heidelberg; Heidelberg Germany
| | - S. Anders
- Genome Biology; EMBL; Heidelberg Germany
| | - J. Lu
- Genome Biology; EMBL; Heidelberg Germany
| | - B. Velten
- Genome Biology; EMBL; Heidelberg Germany
| | - A. Mock
- Genome Biology; EMBL; Heidelberg Germany
| | - C. Oakes
- Division of Hematology; The Ohio State University; Ohio USA
| | - L. Sutton
- Department of Immunology; Genetics and Pathology, Science for Life Laboratory; Uppsala Sweden
| | - E. Young
- Department of Immunology; Genetics and Pathology, Science for Life Laboratory; Uppsala Sweden
| | - R. Rosenquist
- Department of Immunology; Genetics and Pathology, Science for Life Laboratory; Uppsala Sweden
| | - D. Rossi
- Department of Translational Medicine; Amedeo Avogadro University of Eastern Piedmont; Novara Italy
| | | | | | - F. Nguyen-Khac
- Université Pierre et Marie Curie-Paris; Service d'Hématologie; Paris France
| | | | | | | | | | - W. Huber
- Genome Biology; EMBL; Heidelberg Germany
| | - T. Zenz
- Translational Oncology; NCT; Heidelberg Germany
| |
Collapse
|
17
|
Loiseau C, Lemonnier F, Randrianarivelo O, Itzykson R, Becquemin M, Nguyen Quoc S, Uzunov M, Catherinot E, Rivaud E, Sutton L, Vernant J, Couderc L, Dhedin N. Bronchiolite oblitérante post-allogreffe de cellules souches hématopoïétiques : intérêt diagnostique d’une surveillance par spiromètre portable au domicile ? Rev Mal Respir 2016. [DOI: 10.1016/j.rmr.2015.10.715] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
18
|
Abstract
An 82-year-old woman with longstanding medial thigh pain presented with a 5-day history of constipation, vomiting, abdominal pain and distension. She was unable to pass flatus for the preceding 24 hours and had a past history of laparoscopic abdominal surgery. Computed tomography of the abdomen and pelvis revealed a right-sided obturator hernia containing a dilated loop of small bowel. She underwent emergency surgery for a right obturator hernia repair by limited laparotomy and was discharged after an extended stay complicated by postoperative atrial fibrillation.
Collapse
Affiliation(s)
- L Sutton
- Hillingdon Hospitals NHS Foundation Trust , UK
| | - A Myers
- Hillingdon Hospitals NHS Foundation Trust , UK
| | - C Gupte
- Hillingdon Hospitals NHS Foundation Trust , UK
| |
Collapse
|
19
|
Zimmerman RA, Bilaniuk LT, Schut L, Packer RL, Sutton L, Bruce D. Medical imaging of pediatric brain tumors. Prog Exp Tumor Res 2015; 30:61-80. [PMID: 3628820 DOI: 10.1159/000413663] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|
20
|
Hawcutt DB, Ghani AA, Sutton L, Jorgensen A, Zhang E, Murray M, Michael H, Peart I, Smyth RL, Pirmohamed M. Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects. Pharmacogenomics J 2014; 14:542-8. [PMID: 25001883 PMCID: PMC4209173 DOI: 10.1038/tpj.2014.31] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/22/2014] [Revised: 04/23/2014] [Accepted: 05/22/2014] [Indexed: 11/08/2022]
Abstract
Warfarin is used in paediatric populations, but dosing algorithms incorporating pharmacogenetic data have not been developed for children. Previous studies have produced estimates of the effect of polymorphisms in Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase complex subunit 1 (VKORC1) on stable warfarin dosing, but data on time in therapeutic range, initial dosing and adverse effects are limited. Participants (n=97) were recruited, and routine clinical data and salivary DNA samples were collected from all participants and analysed for CYP2C9*2, *3 and VKORC1-1639 polymorphisms.VKORC1 -1639 was associated with a greater proportion of the first 6 months' treatment time spent within the target International Normalised Ratio (INR) range, accounting for an additional 9.5% of the variance in the proportion of time. CYP2C9*2 was associated with a greater likelihood of INR values exceeding the target range during the initiation of treatment (odds ratio (OR; per additional copy) 4.18, 95% confidence interval (CI) 1.42, 12.34). CYP2C9*2 and VKORC1-1639 were associated with a lower dose requirement, and accounted for almost 12% of the variance in stable dose. VKORC1-1639 was associated with an increased likelihood of mild bleeding complications (OR (heterozygotes vs homozygotes) 4.53, 95% CI 1.59, 12.93). These data show novel associations between VKORC1-1639 and CYP2C9*2 and INR values in children taking warfarin, as well as replicating previous findings with regard to stable dose requirements. The development of pharmacogenomic dosing algorithms for children using warfarin has the potential to improve clinical care in this population.
Collapse
Affiliation(s)
- D B Hawcutt
- 1] Institute of Translational Medicine, University of Liverpool, Liverpool, UK [2] Department of Research, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - A A Ghani
- Institute of Translational Medicine, University of Liverpool, Liverpool, UK
| | - L Sutton
- Department of Biostatistics, University of Liverpool, Liverpool, UK
| | - A Jorgensen
- Department of Biostatistics, University of Liverpool, Liverpool, UK
| | - E Zhang
- Institute of Translational Medicine, University of Liverpool, Liverpool, UK
| | - M Murray
- Department of Cardiology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - H Michael
- Department of Cardiology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - I Peart
- Department of Cardiology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - R L Smyth
- Institute of Child Health, University College London (UCL), London, UK
| | - M Pirmohamed
- Institute of Translational Medicine, University of Liverpool, Liverpool, UK
| |
Collapse
|
21
|
Powers TO, Bernard EC, Harris T, Higgins R, Olson M, Lodema M, Mullin P, Sutton L, Powers KS. COI haplotype groups in Mesocriconema (Nematoda: Criconematidae) and their morphospecies associations. Zootaxa 2014; 3827:101-46. [PMID: 25081151 DOI: 10.11646/zootaxa.3827.2.1] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2014] [Indexed: 11/04/2022]
Abstract
Without applying an a priori bias for species boundaries, specimen identities in the plant-parasitic nematode genus Mesocriconema were evaluated by examining mitochondrial COI nucleotide sequences, morphology, and biogeography. A total of 242 specimens that morphologically conformed to the genus were individually photographed, measured, and amplified by a PCR primer set to preserve the linkage between specimen morphology and a specific DNA barcode sequence. Specimens were extracted from soil samples representing 45 locations across 23 ecoregions in North America. Dendrograms constructed by neighbor-joining, maximum likelihood, and Bayesian Inference using a 721-bp COI barcode were used to group COI haplotypes. Each tree-building approach resulted in 24 major haplotype groups within the dataset. The distinctiveness of these groups was evaluated by node support, genetic distance, absence of intermediates, and several measures of distinctiveness included in software used for the exploration of species boundaries. Five of the 24 COI haplotype groups corresponded to morphologically characterized, Linnaean species. Morphospecies conforming to M. discus, Discocriconemella inarata, M. rusticum, M. onoense, and M. kirjanovae were represented by groups composed of multiple closely related or identical COI haplotypes. In other cases, morphospecies names could be equally applied to multiple haplotype groups that were genetically distant from each other. Identification based on morphology alone resulted in M. curvatum and M. ornatum species designations applied to seven and three groups, respectively. Morphological characters typically used for species level identification were demonstrably variable within haplotype groups, suggesting caution in assigning species names based on published compendia that solely consider morphological characters. Morphospecies classified as M. xenoplax formed a monophyletic group composed of seven genetically distinct COI subgroups. The species Discocriconemella inarata is transferred to Mesocriconema inaratum based on its phylogenetic position on the COI tree as well as previous phylogenetic analyses using 18S, ITS1, and cytochrome b nucleotide sequences. This study indicates that some of the species considered cosmopolitan in their distribution are actually multispecies polyphyletic groupings and an accurate assessment of Mesocriconema species distributions will benefit from molecular determination of haplotype relationships. The groups revealed by COI analysis should provide a useful framework for the evaluation of additional Mesocriconema species and will improve the reliability of designating taxonomic units in studies of nematode biodiversity.
Collapse
Affiliation(s)
- T O Powers
- Department of Plant Pathology, University of Nebraska-Lincoln, Lincoln, NE 68583-0722, USA.;
| | - E C Bernard
- Entomology & Plant Pathology, University of Tennessee, 2505 E.J. Chapman Drive, 370 Plant Biotechnology, Knoxville, TN, USA, 37996-4560.;
| | - T Harris
- Department of Plant Pathology, University of Nebraska-Lincoln, Lincoln, NE 68583-0722, USA.;
| | - R Higgins
- Department of Plant Pathology, University of Nebraska-Lincoln, Lincoln, NE 68583-0722, USA.; unknown
| | - M Olson
- Department of Plant Pathology, University of Nebraska-Lincoln, Lincoln, NE 68583-0722, USA.; unknown
| | - M Lodema
- Department of Plant Pathology, University of Nebraska-Lincoln, Lincoln, NE 68583-0722, USA.; unknown
| | - P Mullin
- Department of Plant Pathology, University of Nebraska-Lincoln, Lincoln, NE 68583-0722, USA.; unknown
| | - L Sutton
- Department of Plant Pathology, University of Nebraska-Lincoln, Lincoln, NE 68583-0722, USA.; unknown
| | - K S Powers
- Department of Plant Pathology, University of Nebraska-Lincoln, Lincoln, NE 68583-0722, USA.;
| |
Collapse
|
22
|
Bridges F, Keiber T, Juhas P, Billinge SJL, Sutton L, Wilde J, Kowach GR. Local vibrations and negative thermal expansion in ZrW2O8. Phys Rev Lett 2014; 112:045505. [PMID: 24580469 DOI: 10.1103/physrevlett.112.045505] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/17/2013] [Indexed: 06/03/2023]
Abstract
We present an x-ray pair distribution function (XPDF) analysis and extended x-ray absorption fine structure (EXAFS) data for ZrW2O8 (10-500 K) with a focus on the stiffness of the Zr-O-W linkage. The XPDF is highly sensitive to W-Zr and W-W correlations, but much less so to O-O or W-O correlations. The Zr-W peak in the XPDF data has a weak temperature dependence and, hence, this linkage is relatively stiff and does not permit bending of the Zr-O-W link. We propose that the low energy vibrational modes that lead to negative thermal expansion involve correlated rotations of ZrO6 octahedra that produce large <111> translations of the WO4 tetrahedra, rather than a transverse motion of O atoms that imply a flexible Zr-O-W linkage.
Collapse
Affiliation(s)
- F Bridges
- Department of Physics, University of California, Santa Cruz, California 95064, USA
| | - T Keiber
- Department of Physics, University of California, Santa Cruz, California 95064, USA
| | - P Juhas
- Condensed Matter Physics and Materials Science Department, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - S J L Billinge
- Condensed Matter Physics and Materials Science Department, Brookhaven National Laboratory, Upton, New York 11973, USA and Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA
| | - L Sutton
- Department of Physics, University of California, Santa Cruz, California 95064, USA
| | - J Wilde
- Department of Physics, University of California, Santa Cruz, California 95064, USA
| | - Glen R Kowach
- Department of Chemistry, The City College of New York, The City University of New York, New York, New York 10031 USA
| |
Collapse
|
23
|
Rugo HS, Melisko M, Ben-Baruch NE, Price Hiller J, Dahkil S, Sutton L, Mazanet R, Mittendorf E. Abstract P1-02-07: Discordance for low and intermediate levels (1+ or 2+ by IHC) of HER2 protein expression in the phase III PRESENT trial. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p1-02-07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background
Significant discordance has been described between different laboratories and between testing methodologies for HER2 overexpression and gene amplification. Concern has focused on missing patients who might benefit from treatment with HER2 targeted therapy. Concordance rates between local and central testing for tumors selected for HER2 0-2+ is not well described. We describe discordance rates between local and central testing performed to identify tumors with 1 and 2+ HER2 expression.
Methods
The PRESENT study is a multicenter, multinational, prospective, randomized, double-blind, controlled Phase 3 study assessing efficacy and safety of the peptide vaccine NeuVax, in HLA-A2 and/or A3 positive patients with early stage, node positive breast cancer expressing low and intermediate levels (1/2+ by IHC) of HER2 protein. PRESENT 2-step screening includes HLA testing followed by central lab confirmation of HER2 1 or 2+ expression using the DAKO HercepTest.
Results
215 patients underwent central IHC testing for HER2. Discordance between local and central testing was seen in 54% (117/215); 34% (65/192) of those eligible by local results were ineligible on central testing, and 48% (11/23) of those not eligible by local results were eligible on central testing.
Local testingCentral testing (IHC (%))IHC (n)01+2+3+0 (15)5 (33%)7 (47%3 (20%)—1+ (127)39 (31%)68 (53%)15 (12%)5 (4%)2+ (65)11 (17%)23 (35%)21 (32%)10 (16%)3+ (8)3 (38%)—1 (12%)4 (50%)
Of those with 1 or 2+ local results, 8% (15/192) were found to be 3+ on central testing. Discordant rates varied by geographic location with higher rates seen in Eastern Europe and Russia.
Conclusion
Significant discordance exists between local and central laboratory test results for HER2 expression by IHC even at lower levels of expression, and current tests are defined by their ability to determine 3+ positivity. In order to improve accuracy of testing and to develop a companion diagnostic for NeuVax, the Leica Bond Oracle HER2 IHC System will be incorporated into future HER2 screening for the PRESENT trial.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P1-02-07.
Collapse
Affiliation(s)
- HS Rugo
- University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; Kaplan Medical Center, Rehovot, Israel; Cross Cancer Institute, Edmonton, AB, Canada; Cancer Center of Kansas, Wichita, KS; Galena Biopharma, Inc., Portland, OR; UT MD Anderson Cancer Center, Houston, TX
| | - M Melisko
- University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; Kaplan Medical Center, Rehovot, Israel; Cross Cancer Institute, Edmonton, AB, Canada; Cancer Center of Kansas, Wichita, KS; Galena Biopharma, Inc., Portland, OR; UT MD Anderson Cancer Center, Houston, TX
| | - NE Ben-Baruch
- University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; Kaplan Medical Center, Rehovot, Israel; Cross Cancer Institute, Edmonton, AB, Canada; Cancer Center of Kansas, Wichita, KS; Galena Biopharma, Inc., Portland, OR; UT MD Anderson Cancer Center, Houston, TX
| | - J Price Hiller
- University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; Kaplan Medical Center, Rehovot, Israel; Cross Cancer Institute, Edmonton, AB, Canada; Cancer Center of Kansas, Wichita, KS; Galena Biopharma, Inc., Portland, OR; UT MD Anderson Cancer Center, Houston, TX
| | - S Dahkil
- University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; Kaplan Medical Center, Rehovot, Israel; Cross Cancer Institute, Edmonton, AB, Canada; Cancer Center of Kansas, Wichita, KS; Galena Biopharma, Inc., Portland, OR; UT MD Anderson Cancer Center, Houston, TX
| | - L Sutton
- University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; Kaplan Medical Center, Rehovot, Israel; Cross Cancer Institute, Edmonton, AB, Canada; Cancer Center of Kansas, Wichita, KS; Galena Biopharma, Inc., Portland, OR; UT MD Anderson Cancer Center, Houston, TX
| | - R Mazanet
- University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; Kaplan Medical Center, Rehovot, Israel; Cross Cancer Institute, Edmonton, AB, Canada; Cancer Center of Kansas, Wichita, KS; Galena Biopharma, Inc., Portland, OR; UT MD Anderson Cancer Center, Houston, TX
| | - E Mittendorf
- University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; Kaplan Medical Center, Rehovot, Israel; Cross Cancer Institute, Edmonton, AB, Canada; Cancer Center of Kansas, Wichita, KS; Galena Biopharma, Inc., Portland, OR; UT MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
24
|
Gunnell D, Bennewith O, Simkin S, Cooper J, Klineberg E, Rodway C, Sutton L, Steeg S, Wells C, Hawton K, Kapur N. Time trends in coroners' use of different verdicts for possible suicides and their impact on officially reported incidence of suicide in England: 1990-2005. Psychol Med 2013; 43:1415-1422. [PMID: 23113986 DOI: 10.1017/s0033291712002401] [Citation(s) in RCA: 80] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
BACKGROUND Official suicide statistics for England are based on deaths given suicide verdicts and most cases given an open verdict following a coroner's inquest. Previous research indicates that some deaths given accidental verdicts are considered to be suicides by clinicians. Changes in coroners' use of different verdicts may bias suicide trend estimates. We investigated whether suicide trends may be over- or underestimated when they are based on deaths given suicide and open verdicts. Method Possible suicides assessed by 12 English coroners in 1990/91, 1998 and 2005 and assigned open, accident/misadventure or narrative verdicts were rated by three experienced suicide researchers according to the likelihood that they were suicides. Details of all suicide verdicts given by these coroners were also recorded. RESULTS In 1990/91, 72.0% of researcher-defined suicides received a suicide verdict from the coroner, this decreased to 65.4% in 2005 (p trend < 0.01); equivalent figures for combined suicide and open verdicts were 95.4% (1990/91) and 86.7% (2005). Researcher-defined suicides with a verdict of accident/misadventure doubled over that period, from 4.6% to 9.1% (p < 0.01). Narrative verdict cases rose from zero in 1990/91 to 25 in 2005 (4.2% of researcher-defined suicides that year). In 1998 and 2005, 50.0% of the medicine poisoning deaths given accidental/misadventure verdicts were rated as suicide by the researchers. CONCLUSIONS Between 1990/91 and 2005, the proportion of researcher-defined suicides given a suicide verdict by coroners decreased, largely due to an increased use of accident/misadventure verdicts, particularly for deaths involving poisoning. Consideration should be given to the inclusion of 'accidental' deaths by poisoning with medicines in the statistics available for monitoring suicides rates.
Collapse
Affiliation(s)
- D Gunnell
- School of Social and Community Medicine, University of Bristol, UK.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Musumba C, Jorgensen A, Sutton L, Van Eker D, Moorcroft J, Hopkins M, Pritchard DM, Pirmohamed M. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. Aliment Pharmacol Ther 2012; 36:48-56. [PMID: 22554233 DOI: 10.1111/j.1365-2036.2012.05118.x] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/13/2012] [Revised: 02/29/2012] [Accepted: 04/13/2012] [Indexed: 12/14/2022]
Abstract
BACKGROUND Recent data from Western countries indicate that the aetiology of peptic ulcer disease (PUD) is changing as the prevalence of Helicobacter pylori is decreasing while the use of low-dose aspirin (LDA, ≤325 mg/day) is increasing. AIM To investigate the changing aetiology and demographics of PUD in a well-characterised patient cohort at a large tertiary hospital in the UK between July 2005 and June 2010. METHODS Patients diagnosed with PUD following endoscopy were categorised as non-steroidal anti-inflammatory drug (NSAID)-users or non-users, and their H. pylori status determined. Comparisons between NSAID-users and non-users, and between non-aspirin NSAID-users and LDA-users were summarised using counts and corresponding percentages (for categorical variables) and means and standard deviations (for continuous variables). RESULTS Overall, 386 patients were enrolled; 57% used NSAIDs (51% LDA only) and 43% were non-users. 57% of the whole cohort was H. pylori-positive (including 66% with duodenal ulcers and 47% with gastric ulcers). Compared with non-users, NSAID-users were older (mean age 68 vs. 61 years) and fewer were H. pylori-positive (52% vs. 63%). LDA-users were older (mean age 71 vs. 62 years) and more likely to be H. pylori-positive (61% vs. 41%) than those using non-aspirin NSAIDs. Twelve per cent of the patients were neither using NSAIDs nor were H. pylori-positive. CONCLUSIONS The NSAIDs, particularly LDA, were most commonly associated with PUD in this cohort. Our findings are compatible with the decline in the prevalence of H. pylori-positive PUD and increase in non-NSAID, non-H. pylori PUD previously reported.
Collapse
Affiliation(s)
- C Musumba
- Department of Molecular, Institute of Translational Medicine, University of Liverpool, UK
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Houot R, Le Gouill S, Ojeda Uribe M, Mounier C, Courby S, Dartigeas C, Bouabdallah K, Alexis Vigier M, Moles M, Tournilhac O, Arakelyan N, Rodon P, El Yamani A, Sutton L, Fornecker L, Assouline D, Harousseau J, Maisonneuve H, Caulet-Maugendre S, Gressin R. Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS. Ann Oncol 2012; 23:1555-61. [DOI: 10.1093/annonc/mdr450] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
27
|
Miller S, Wu W, Sutton L, Lee L. Ocular Safety of Fluticasone furoate Nasal Spray in Subjects with Perennial Allergic Rhinitis. J Allergy Clin Immunol 2012. [DOI: 10.1016/j.jaci.2011.12.450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
28
|
Tester E, Sutton L, Duckworth L. Evaluation of nutrition knowledge and dietary intake of male academy rugby union players undertaking a nutrition education program. Br J Sports Med 2011. [DOI: 10.1136/bjsports-2011-090606.3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
29
|
Wilkinson-Berka JL, Tan G, Binger KJ, Sutton L, McMaster K, Deliyanti D, Perera G, Campbell DJ, Miller AG. Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat. Diabetologia 2011; 54:2724-35. [PMID: 21755314 DOI: 10.1007/s00125-011-2239-9] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/20/2011] [Accepted: 06/13/2011] [Indexed: 10/18/2022]
Abstract
AIM/HYPOTHESIS We examined whether the renin inhibitor, aliskiren, provides similar or greater protection than ACE inhibition from non-proliferative diabetic retinopathy and from the proliferative neoangiogenesis of oxygen-induced retinopathy. METHODS Transgenic (mRen-2)27 rats, which overexpress mouse renin and angiotensin in extra-renal tissues, were studied. For diabetic studies, non-diabetic, diabetic (streptozotocin, 55 mg/kg), diabetic + aliskiren (10 mg kg(-1) day(-1), pump), or diabetic + lisinopril (10 mg kg(-1) day(-1), drinking water) rats were evaluated over 16 weeks. For oxygen-induced retinopathy studies, rats were exposed to 80% oxygen (22 h/day) from postnatal days 0 to 11, and then room air from postnatal days 12 to 18. Aliskiren (10 or 30 mg kg(-1) day(-1), pump) or lisinopril (10 mg kg(-1) day(-1), drinking water) was administered during retinopathy development between postnatal days 12 and 18. RESULTS Systolic BP in diabetic (mRen-2)27 rats was reduced with 10 mg kg(-1) day(-1) aliskiren, but only lisinopril normalised systolic blood pressure. In diabetic (mRen-2)27 rats, 10 mg kg(-1) day(-1) aliskiren and lisinopril reduced retinal acellular capillaries and leucostasis to non-diabetic levels. In oxygen-induced retinopathy, neoangiogenesis and retinal inflammation (leucostasis, ED-1 immunolabelling) were partially reduced by 10 mg kg(-1) day(-1) aliskiren and normalised by 30 mg kg(-1) day(-1) aliskiren, whereas lisinopril normalised neoangiogenesis and reduced leucostasis and ED-1 immunolabelling. Aliskiren and lisinopril normalised retinal vascular endothelial growth factor expression; however, only aliskiren reduced intercellular adhesion molecule-1 to control levels. CONCLUSIONS/INTERPRETATION Aliskiren provided similar or greater retinal protection than ACE inhibition and may be a potential treatment for diabetic retinopathy.
Collapse
Affiliation(s)
- J L Wilkinson-Berka
- Department of Immunology, Monash University, Alfred Medical Research and Education Precinct (AMREP), Commercial Road, Melbourne, 3004 Victoria, Australia.
| | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Goold R, Rabbanian S, Sutton L, Andre R, Arora P, Moonga J, Clarke AR, Schiavo G, Jat P, Collinge J, Tabrizi SJ. Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun 2011; 2:281. [PMID: 21505437 PMCID: PMC3104518 DOI: 10.1038/ncomms1282] [Citation(s) in RCA: 114] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2010] [Accepted: 03/17/2011] [Indexed: 11/09/2022] Open
Abstract
Prion diseases are fatal neurodegenerative disorders with unique transmissible properties. The infectious and pathological agent is thought to be a misfolded conformer of the prion protein. Little is known about the initial events in prion infection because the infecting prion source has been immunologically indistinguishable from normal cellular prion protein (PrP(C)). Here we develop a unique cell system in which epitope-tagged PrP(C) is expressed in a PrP knockdown (KD) neuroblastoma cell line. The tagged PrP(C), when expressed in our PrP-KD cells, supports prion replication with the production of bona fide epitope-tagged infectious misfolded PrP (PrP(Sc)). Using this epitope-tagged PrP(Sc), we study the earliest events in cellular prion infection and PrP misfolding. We show that prion infection of cells is extremely rapid occurring within 1 min of prion exposure, and we demonstrate that the plasma membrane is the primary site of prion conversion.
Collapse
Affiliation(s)
- R Goold
- Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Le Gouill S, Milpied NJ, Lamy T, Delwail V, Gressin R, Guyotat D, Damaj GL, Foussard C, Cartron G, Maisonneuve H, Deconinck E, Dreyfus F, Gyan E, Sutton L, Morineau N, Alexis M, Perry F, Sauvezie M. First-line rituximab (R) high-dose therapy (R-HDT) versus R-CHOP14 for young adults with diffuse large B-cell lymphoma: Preliminary results of the GOELAMS 075 prospective multicenter randomized trial. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.8003] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
32
|
Owusu C, Klepin HD, Kimmick GG, Sutton L, Brufsky A. Safety and efficacy of single-agent adjuvant trastzumab in older women with breast cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.tps109] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
33
|
Oortgiesen JM, DiMichele LA, Weidman JR, Gunto VT, Soeder T, Cato A, Sutton L. Immune response to gastrin-17 and survival in gastrointestinal cancers. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e14541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
34
|
Hopkins ND, Green DJ, Tinken TM, Sutton L, McWhannell N, Cable NT, Stratton G, George K. Does brachial artery flow-mediated dilation scale to anthropometric characteristics? Eur J Appl Physiol 2010; 110:171-6. [PMID: 20440622 DOI: 10.1007/s00421-010-1490-y] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/19/2010] [Indexed: 12/20/2022]
Abstract
Flow-mediated dilation (FMD) assesses the health of the vascular endothelium. Despite widespread adoption of scaling practices in cardiac research, scaling for body size or composition has not been used for FMD. The present study investigated the relationships between brachial FMD and body composition in 129 children aged 9-10 (75 female symbol, 54 male symbol), and 50 men aged 16-49. Body composition variables (total, lean, fat mass in the whole body, arm, forearm) were assessed by dual-energy X-ray absorptiometry, FMD was measured in the brachial artery using high-resolution ultrasound. FMD was scaled using simple ratios (y/x) and allometric approaches (y/x ( b )) after log-log least squares linear regression produced allometric exponents (b). Size independence was confirmed via bivariate correlations (x:y/x; x:y/x ( b )). No relationships were evident between FMD and body composition variables in adults. Small correlations existed between FMD and measures of segmental fat mass in children (r = -0.18 to -0.19, p < 0.05), there were no significant relationships between FMD and measures of lean or total mass in children. For all significant relationships, b-exponents were different from 1 (CIs -0.36 to 0.07), suggesting ratio scaling approaches were flawed. This was confirmed when ratio scaling produced negative residual size correlations, whereas allometric scaling produced size-independent indices. Correlations between FMD and body composition were weak in children and insignificant in adults. As the results of this study are limited to the populations examined, our findings do not support the adoption of scaling procedures to correct FMD.
Collapse
Affiliation(s)
- N D Hopkins
- Research Institute for Sport and Exercise Science, Liverpool John Moore's University, Liverpool, L3 2ET, UK
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Chopra M, Amor DJ, Sutton L, Algar E, Mowat D. Russell-Silver syndrome due to paternal H19/IGF2 hypomethylation in a patient conceived using intracytoplasmic sperm injection. Reprod Biomed Online 2010; 20:843-7. [PMID: 20385510 DOI: 10.1016/j.rbmo.2010.02.025] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2009] [Revised: 02/14/2010] [Accepted: 02/16/2010] [Indexed: 12/28/2022]
Abstract
Epigenetic alterations at several maternal loci have been associated with imprinting disorders in children conceived using assisted reproductive technologies. To date, epimutations at paternal loci have been observed in the spermatozoa of infertile men, but there is little evidence of paternal epimutations in babies conceived using assisted reproductive treatment. This is a report of a female infant with classic Russell-Silver Syndrome (RSS) who was conceived using intracytoplasmic injection of spermatozoa obtained from testicular aspiration. Methylation studies revealed hypomethylation of the paternally derived H19/IGF2 locus. As far as is known, this is the second assisted reproduction treatment-conceived patient with classic RSS and this epigenotype. This case provides further evidence that epimutations affecting paternal alleles might be associated with assisted reproductive treatment.
Collapse
Affiliation(s)
- M Chopra
- Department of Medical Genetics, Sydney Children's Hospital, Sydney, Australia
| | | | | | | | | |
Collapse
|
36
|
Fitzpatrick R, Chambers J, Burns T, Doll H, Fazel S, Jenkinson C, Kaur A, Knapp M, Sutton L, Yiend J. A systematic review of outcome measures used in forensic mental health research with consensus panel opinion. Health Technol Assess 2010; 14:1-94. [DOI: 10.3310/hta14180] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Affiliation(s)
- R Fitzpatrick
- Department of Public Health, University of Oxford, Oxford, UK
| | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Knobil K, Yancey S, Kral K, Sutton L. Meta-analysis of Serious Asthma-related Outcomes in Subjects Receiving Advair®. J Allergy Clin Immunol 2010. [DOI: 10.1016/j.jaci.2009.12.274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
38
|
Hopkins ND, Green DJ, Tinken TM, Sutton L, McWhannell N, Thijssen DHJ, Cable NT, Stratton G, George K. Does conduit artery diameter vary according to the anthropometric characteristics of children or men? Am J Physiol Heart Circ Physiol 2009; 297:H2182-7. [PMID: 19837946 DOI: 10.1152/ajpheart.00228.2009] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Arterial measurements are commonly undertaken to assess acute and chronic adaptations to exercise. Despite the widespread adoption of scaling practices in cardiac research, the relevance of scaling for body size and/or composition has not been addressed for arterial measures. We therefore investigated the relationships between brachial artery diameter and body composition in 129 children aged 9 to 10 yr (75 girls and 54 boys), and 50 men aged 16-49 yr. Body composition variables (total, lean, and fat mass in the whole body, arm, and forearm) were assessed by dual-energy X-ray absorptiometry, and brachial artery diameter was measured using high-resolution ultrasound. Bivariate correlations were performed, and arterial diameter was then scaled using simple ratios (y/x) and allometric approaches after log-log least squares linear regression and production of allometric exponents (b) and construction of power function ratios (y/xb). Size independence was checked via bivariate correlations (x:y/x; x:y/xb). As a result, significant correlations existed between brachial artery diameter and measures of body mass and lean mass in both cohorts (r=0.21-0.48, P<0.05). There were no significant relationships between diameter and fat mass. All b exponents were significantly different from 1 (0.08-0.50), suggesting that simple ratio scaling approaches were likely to be flawed. This was confirmed when ratio scaling produced negative residual size correlations, whereas allometric scaling produced size-independent indexes (r=0.00 to 0.03, P>0.05). In conclusion, when between- or within-group comparisons are performed under circumstances where it is important to control for differences in body size or composition, allometric scaling of artery diameter should be adopted rather than ratio scaling. Our data also suggest that scaling for lean or total mass may be more appropriate than scaling for indexes of fat mass.
Collapse
Affiliation(s)
- N D Hopkins
- Research Institute for Sport and Exercise Science, Liverpool John Moores University, 15-21 Webster St., Liverpool, L3 2ET, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
39
|
|
40
|
Barr D, Gregson W, Sutton L, Reilly T. A practical cooling strategy for reducing the physiological strain associated with firefighting activity in the heat. Ergonomics 2009; 52:413-420. [PMID: 19401892 DOI: 10.1080/00140130802707675] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
The aim of this study was to establish whether a practical cooling strategy reduces the physiological strain during simulated firefighting activity in the heat. On two separate occasions under high ambient temperatures (49.6 +/- 1.8 degrees C, relative humidity (RH) 13 +/- 2%), nine male firefighters wearing protective clothing completed two 20-min bouts of treadmill walking (5 km/h, 7.5% gradient) separated by a 15-min recovery period, during which firefighters were either cooled (cool) via application of an ice vest and hand and forearm water immersion ( approximately 19 degrees C) or remained seated without cooling (control). There was no significant difference between trials in any of the dependent variables during the first bout of exercise. Core body temperature (37.72 +/- 0.34 vs. 38.21 +/- 0.17 degrees C), heart rate (HR) (81 +/- 9 vs. 96 +/- 17 beats/min) and mean skin temperature (31.22 +/- 1.04 degrees C vs. 33.31 +/- 1 degrees C) were significantly lower following the recovery period in cool compared with control (p < 0.05). Core body temperature remained consistently lower (0.49 +/- 0.02 degrees C; p < 0.01) throughout the second bout of activity in cool compared to control. Mean skin temperature, HR and thermal sensation were significantly lower during bout 2 in cool compared with control (p < 0.05). It is concluded that this practical cooling strategy is effective at reducing the physiological strain associated with demanding firefighting activity under high ambient temperatures.
Collapse
Affiliation(s)
- D Barr
- Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
| | | | | | | |
Collapse
|
41
|
Reilly T, George K, Marfell-Jones M, Scott M, Sutton L, Wallace JA. How well do skinfold equations predict percent body fat in elite soccer players? Int J Sports Med 2009; 30:607-13. [PMID: 19301213 DOI: 10.1055/s-0029-1202353] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
The use of generic equations for estimating percent body fat from skinfold thicknesses can be criticised when applied to specific sports. The present aims were to compare existing methods of using skinfold data and to derive an equation for predicting body fat values in professional soccer players. Forty-five professional soccer players (24.2 +/- 5.0 years; 82.0 +/- 8.5 kg; 1.82 +/- 0.07 m) participated. Skinfold thicknesses were assessed at eight sites for the application of existing prediction equations. Skinfold data were also utilised to determine a novel soccer-specific equation. All players had a reference estimate of percent fat by dual-energy x-ray absorptiometry (DXA). The existing skinfold equations differed from the DXA-referenced values by varying degrees, the equation of Withers et al. (1987) demonstrating the lowest bias and highest relationship and agreement with DXA. Regression analysis resulted in an equation incorporating anterior thigh, abdominal, triceps and medial calf sites, accounting for 78.4% variance in DXA criterion values.
Collapse
Affiliation(s)
- T Reilly
- Research Institute for Sport & Exercise Sciences, Liverpool John Moores University, Liverpool, United Kingdom.
| | | | | | | | | | | |
Collapse
|
42
|
Abstract
Wheelchair users undergo changes in body composition as a result of disability. In this study the distribution of bone mineral, lean and fat mass was assessed in highly-trained female wheelchair athletes and a reference group by dual-energy X-ray absorptiometry (DXA). The transferability of anthropometric equations commonly used in female groups was examined in order to establish a suitable field method of body composition assessment. The DXA total-body results indicated no difference between groups, but segmental analyses uncovered regional differences. The wheelchair athletes had greater BMD (p=0.088), more lean mass (p<0.001) and a lower percent fat (p=0.050) in their arms. The reverse was true of the legs (p< or =0.001). The trunk as a whole did not differ between groups. In general, the anthropometric equations showed a lack of transferability to the wheelchair group and tended to underestimate total percent body fat. Anthropometric measures such as body mass index (BMI) and waist girth showed strong correlations with body fat in the wheelchair group (BMI: r=0.90, p=0.001; waist: r=0.83, p=0.001), but weaker results in the reference group. It is recommended that specific anthropometric equations be developed for use in the absence of a 'gold standard' measure of body composition such as DXA.
Collapse
Affiliation(s)
- L Sutton
- Sport and Exercise Science, Liverpool John Moores University, Liverpool, United Kingdom.
| | | | | | | | | |
Collapse
|
43
|
Abstract
Excellent palliative care is available for patients with advanced lung cancer. Whether the same services are available for those with nonmalignant respiratory disease is less clear. A questionnaire was sent to 210 named respiratory physicians, each representing a major hospital in England, Wales, and Northern Ireland. A total of 107 replies were received; the response rate was 51.0%. Respondents cared for patients with chronic obstructive pulmonary disease, asbestosis, and diffuse parenchymal lung disease but only a third had responsibility for cystic fibrosis. Physicians were supported by a mean of 3.4 respiratory nurse specialists per department and 73.8% had a specialist lung cancer nurse. In only 16 cases (20.3%) did that nurse extend care to those with nonmalignant disease. Only a minority reported easy access to hospice in-patient care or day care. About 21.5% of the respondents had formal policies in place for care of patients with chronic respiratory disease nearing the end of life, but 87.9% of respondents had no formal process for initiating end of life discussions with those with terminal respiratory illness. Patients with advanced nonmalignant respiratory disease have less universal access to specialist palliative care services than do those with malignant lung disease, and in the majority of hospitals there is no formalized approach to end of life care issues with patients with chronic lung disease.
Collapse
Affiliation(s)
- MR Partridge
- Imperial College London, NHLI, Division at Charing Cross Hospital, London, UK
| | - A Khatri
- Data Analyst and Policy Officer, The National Council for Palliative Care, London, UK
| | - L Sutton
- Director of Policy Development, The National Council for Palliative Care, London, UK
| | - S Welham
- Deputy CEO, The British Thoracic Society, London, UK
| | - SH Ahmedzai
- Academic Unit of Supportive Care, The University of Sheffield, Sheffield, UK
| |
Collapse
|
44
|
Yedjou C, Sutton L, Tchounwou P. GENOTOXIC MECHANISMS OF ARSENIC TRIOXIDE IN HUMAN JURKAT T-LYMPHOMA CELLS. Met Ions Biol Med 2008; 10:495-499. [PMID: 21796259 PMCID: PMC3142934] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Arsenic trioxide (As(2)O(3)) has cytotoxic effects on several cancer cell lines. However, the molecular mechanisms of action remain to be elucidated. Hence, the aim of the present study was to evaluate the cytotoxicity and genotoxicity induced by As(2)O(3) in a human Jurkat T-lymphoma cell line using the trypan blue exclusion test and alkaline single cell gel electrophoresis (Comet) assays, respectively. Jurkat T-cells were treated with different doses of As(2)O(3) for 24 and 48 h prior to cytogenetic assessment. Data obtained from the trypan blue exclusion test indicated that As(2)O(3) significantly (p < 0.05) reduced the viability of Jurkat T-cells in a dose and time-dependent manner. Data generated from the comet assay also indicated a significant dose and time-dependent increase in DNA damage in Jurkat T-cells associated with As(2)O(3) exposure. We observed a significant increase (P < 0.05) in comet tail-length, tail arm and tail moment, as well as in percentages of DNA cleavage at all doses tested, showing an evidence As(2)O(3) -induced genotoxic damage in Jurkat T-cells. This study confirms that the comet assay is a sensitive and effective method to detect DNA damage caused by heavy metals such as arsenic. Taken together, our findings suggest that As(2)O(3) exposure significantly (p < 0.05) reduces cellular viability and induces DNA damage in human Jurkat T-lymphoma cells.
Collapse
|
45
|
Abdel-Latif ME, Bajuk B, Oei J, Vincent T, Sutton L, Lui K. Does rural or urban residence make a difference to neonatal outcome in premature birth? A regional study in Australia. Arch Dis Child Fetal Neonatal Ed 2006; 91:F251-6. [PMID: 16428354 PMCID: PMC2672724 DOI: 10.1136/adc.2005.090670] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND Patients living in rural areas may be at a disadvantage in accessing tertiary health care. AIM To test the hypothesis that very premature infants born to mothers residing in rural areas have poorer outcomes than those residing in urban areas in the state of New South Wales (NSW) and the Australian Capital Territory (ACT) despite a coordinated referral and transport system. METHODS "Rural" or "urban" status was based on the location of maternal residence. Perinatal characteristics, major morbidity and case mix adjusted mortality were compared between 1879 rural and 6775 urban infants <32 weeks gestational age, born in 1992-2002 and admitted to all 10 neonatal intensive care units in NSW and ACT. RESULTS Rural mothers were more likely to be teenaged, indigenous, and to have had a previous premature birth, prolonged ruptured membrane, and antenatal corticosteroid. Urban mothers were more likely to have had assisted conception and a caesarean section. More urban (93% v 83%) infants were born in a tertiary obstetric hospital. Infants of rural residence had a higher mortality (adjusted odds ratio (OR) 1.26, 95% confidence interval (CI) 1.07 to 1.48, p = 0.005). This trend was consistently seen in all subgroups and significantly for the tertiary hospital born population and the 30-31 weeks gestation subgroup. Regional birth data in this gestational age range also showed a higher stillbirth rate among rural infants (OR 1.20, 95% CI 1.09 to 1.32, p<0.001). CONCLUSIONS Premature births from rural mothers have a higher risk of stillbirth and mortality in neonatal intensive care than urban infants.
Collapse
Affiliation(s)
- M E Abdel-Latif
- Department of Newborn Care, Royal Hospital for Women, Barker Street, Locked Bag 2000, Randwick, 2031 NSW, Australia
| | | | | | | | | | | |
Collapse
|
46
|
Bendell JC, Fernando N, Morse M, Blobe G, Yu D, Sutton L, Schaffer S, Honeycutt W, Franklin A, Hurwitz H. A phase II study of oxaliplatin (OX), capecitabine (CAP), and bevacizumab (BV) in the treatment of metastatic colorectal cancer. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.3541] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
3541 Background: BV, a monoclonal antibody against vascular endothelial growth factor, provides a survival advantage when added to first line therapy for metastatic colorectal cancer. CAP allows for fluoropyrimide treatment without the inconvenience of an infusion pump. We aimed to investigate the combination of OX, CAP, and BV (XeloxA) as a more convenient and active regimen. Methods: Pts with untreated metastatic colorectal cancer received OX 85 mg/m2 d1, CAP 1000 mg/m2 BID d1–5 and 8–12, and BV 10 mg/kg d1. Cycles were repeated every two weeks. The starting dose of CAP was changed to 850 mg/m2 BID due to toxicity in the first 28 patients. Data were analyzed under an intention to treat method. Results: 50 pts received therapy (28M, 22F), median age 55 (range 24–81). Data were available on 49 pts. The most common toxicity was diarrhea, with 12/49 (24%) having grade 3 diarrhea, and 22% with grade 2. After the dose reduction of CAP, 3/21 (14%) pts had grade 3 diarrhea and 2/21 (10%) with grade 2 as compared to 32% grade 3 and 32% grade 2 at the higher dose. At the higher dose of CAP 4% of pts had grade 3 hand-foot syndrome (HFS) and 39% had grade 2. At the lower dose, 10% had grade 3 and 5% had grade 2. Other grade 3 toxicities were minimal, including neurotoxicity (8%), vomiting (6%), and neutropenia (4%). There were 23 responses, 1 CR and 22 PR (RR=47%; 95% CI: 33%-62%). 21 pts had stable disease (43%). Median progression free survival (PFS) was 10.7 months (95% CI: 8.6–13.6). Conclusions: XeloxA is a well tolerated, active regimen in the first line treatment of metastatic colorectal cancer. RR and PFS data approximate that of infusional 5-FU regimens in combination with BV without the necessity of an infusion pump. [Table: see text]
Collapse
Affiliation(s)
- J. C. Bendell
- Duke University Medical Center, Durham, NC; Georgia Cancer Specialists, Atlanta, GA
| | - N. Fernando
- Duke University Medical Center, Durham, NC; Georgia Cancer Specialists, Atlanta, GA
| | - M. Morse
- Duke University Medical Center, Durham, NC; Georgia Cancer Specialists, Atlanta, GA
| | - G. Blobe
- Duke University Medical Center, Durham, NC; Georgia Cancer Specialists, Atlanta, GA
| | - D. Yu
- Duke University Medical Center, Durham, NC; Georgia Cancer Specialists, Atlanta, GA
| | - L. Sutton
- Duke University Medical Center, Durham, NC; Georgia Cancer Specialists, Atlanta, GA
| | - S. Schaffer
- Duke University Medical Center, Durham, NC; Georgia Cancer Specialists, Atlanta, GA
| | - W. Honeycutt
- Duke University Medical Center, Durham, NC; Georgia Cancer Specialists, Atlanta, GA
| | - A. Franklin
- Duke University Medical Center, Durham, NC; Georgia Cancer Specialists, Atlanta, GA
| | - H. Hurwitz
- Duke University Medical Center, Durham, NC; Georgia Cancer Specialists, Atlanta, GA
| |
Collapse
|
47
|
Jarjour N, Dorinsky P, Stauffer J, Reilly D, Yancey S, Edwards L, Sutton L. Control of Airway Inflammation in Asthma Patients Receiving Fluticasone Propionate (FP)/Salmeterol, FP Alone or FP Plus Montelukast. J Allergy Clin Immunol 2006. [DOI: 10.1016/j.jaci.2005.12.370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
48
|
Torres-Rodriguez A, Sartor C, Higgins S, Wolfenden A, Bielke L, Pixley C, Sutton L, Tellez G, Hargis B. Effect of Aspergillus Meal Prebiotic (Fermacto) on Performance of Broiler Chickens in the Starter Phase and Fed Low Protein Diets. J APPL POULTRY RES 2005. [DOI: 10.1093/japr/14.4.665] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
49
|
Alimohamad H, Sutton L, Mouyal J, Rajakumar N, Rushlow WJ. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats. J Neurochem 2005; 95:513-25. [PMID: 16144542 DOI: 10.1111/j.1471-4159.2005.03388.x] [Citation(s) in RCA: 79] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Protein kinase B and glycogen synthase kinase-3 have been identified as susceptibility genes for schizophrenia and altered protein and mRNA levels have been detected in the brains of schizophrenics post-mortem. Recently, we reported that haloperidol, clozapine and risperidone alter glycogen synthase kinase-3 and beta-catenin protein expression and glycogen synthase kinase-3 phosphorylation levels in the rat prefrontal cortex and striatum. In the current study, beta-catenin, adenomatous polyposis coli, Wnt1, dishevelled and glycogen synthase kinase-3 were examined in the ventral midbrain and hippocampus using western blotting. In addition, beta-catenin and GSK-3 were examined in the substantia nigra and ventral tegmental area using confocal and fluorescence microscopy. The results indicate that repeated antipsychotic administration results in significant elevations in glycogen synthase kinase-3, beta-catenin and dishevelled-3 protein levels in the ventral midbrain and hippocampus. Raclopride causes similar changes in beta-catenin and GSK-3 in the ventral midbrain, suggesting that D2 dopamine receptor antagonism mediated the changes observed following antipsychotic administration. In contrast, amphetamine, a drug capable of inducing psychotic episodes, had the opposite effect on beta-catenin and GSK-3 in the ventral midbrain. Collectively, the results suggest that antipsychotics may exert their beneficial effects through modifications to proteins that are associated with the canonical Wnt pathway.
Collapse
Affiliation(s)
- H Alimohamad
- Department of Anatomy and Cell Biology, The University of Western Ontario and The London Health Sciences Centre, London, Ontario, Canada
| | | | | | | | | |
Collapse
|
50
|
Abstract
BACKGROUND Suicide by self-poisoning is an important cause of death worldwide. A substantial proportion of those with a fatal outcome may come into contact with medical services before they die. AIM To estimate the proportion of self-poisoning suicides who reached hospital alive; to compare those who reached hospital alive with those who did not; to describe in detail the clinical characteristics and medical management of those dying in hospital. DESIGN Retrospective audit. METHODS We studied 24 coroners' jurisdictions across England, reviewing coroners' files and identifying all suicides by self-poisoning (drugs and other ingestible poisons) from 1 January 2001 to 31 December 2001. RESULTS Of the 214 individuals who completed suicide by self-poisoning during the study period, 49 (23%) reached hospital alive. Those reaching hospital were more likely to be female, more likely to have ingested paracetamol and less likely to have ingested co-proxamol. In the hospital sample, the commonest causes of death were respiratory (n = 10), hepatic or hepatorenal (n = 8), cardiac (n = 5), or a result of hypoxic brain injury (n = 5). Only 18% of in-hospital deaths occurred within 24 h of the overdose. DISCUSSION Extrapolating to England as a whole, we might expect 300 self-poisoning suicides per year to reach hospital alive (6% of all suicides). Improved medical management might produce a small but significant reduction in the rate of suicide. Such interventions should not be restricted to the emergency care domain. Further research will help to clarify the likely contribution of improved medical management to suicide prevention.
Collapse
Affiliation(s)
- N Kapur
- Centre for Suicide Prevention, Williamson Building, University of Manchester, Oxford Road, Manchester M13 9PL.
| | | | | | | | | | | | | | | |
Collapse
|